{
    "url_original": "https://www.wsj.com/articles/biotech-startups-seeking-to-boost-new-drug-targets-win-venture-funding-11653559207?mod=markets_featst_pos3",
    "url": "biotech-startups-seeking-to-boost-new-drug-targets-win-venture-funding-11653559207",
    "title": "Biotech Startups Seeking to Boost New Drug Targets Win Venture Funding",
    "sub_head": "Venture-capital firms are backing companies working to tackle the problem of ‘undruggable’ proteins",
    "time": "2022-05-26 06:00:00",
    "body": "Venture capitalists are financing startups seeking to increase the number of molecular targets for drugmakers to pursue, potentially enabling new treatments for cancer and other diseases.<br />Many drugs work by inhibiting proteins involved in a disease. But the number of proteins accessible to drugmakers is limited because most disease-associated proteins are considered “undruggable,” meaning scientists have been unable to develop compounds against them, investors and entrepreneurs said.<br />Startups..."
}